EvanFox22 Profile Banner
Evan Fox Profile
Evan Fox

@EvanFox22

Followers
100
Following
15K
Media
33
Statuses
659

Joined March 2012
Don't wanna be here? Send us removal request.
@EvanFox22
Evan Fox
2 years
A major accomplishment worthy of vast recognition and praise. Congrats to the entire team @LyGenesis_Inc on this major milestone!
@LyGenesis_Inc
LyGenesis
2 years
Congratulations to LyGenesis on the successful dosing of their first patient in the Ph2a clinical trial for End-Stage Liver Disease! #LyGenesis #clinicaltrial #liverdisease #regenerativemedicine #ESLD https://t.co/FI8jiTbOab
0
0
1
@EvanFox22
Evan Fox
2 years
Congrats to @LyGenesis_Inc @MichaelHufford on the latest financing! Can't wait to read about more progress with your groundbreaking therapies.
0
0
1
@EvanFox22
Evan Fox
3 years
〽️ Go Blue! So incredibly proud. I know @JP_summit41 is smiling huge somewhere after setting the entire D1 process in motion many years back and building this foundation for success.
@UMichLacrosse
Michigan Men's Lacrosse
3 years
𝙱𝙸𝙢 πšƒπ™΄π™½ πšƒπ™Ύπš„πšπ™½π™°π™Όπ™΄π™½πšƒ π™²π™·π™°π™Όπ™Ώπ™Έπ™Ύπ™½πš‚ No. 15 Michigan 14, No. 7 Maryland 5 βœ…NCAA Tournament Bound βœ… Big Ten Tournament Champions #GoBlue〽️
0
0
5
@EvanFox22
Evan Fox
4 years
Fantastic presentation by Greg discussing the unique approach of @juvlabs along with their diverse, expansive, and still growing pipeline. Amazing team aiming to produce amazing results to help #reimaginealifetime 🀚🏻
0
0
5
@EvanFox22
Evan Fox
4 years
Fantastic work from the brilliant @drmichaellevin and many, many others! Congrats again bud πŸ™ŒπŸ»
@drmichaellevin
Michael Levin
4 years
Super excited to see this come out: https://t.co/6Cfe4LfhHL @msahsorin, @kaplan_lorax, and many others. Key points: 1) Just 24 hour stimulation with our MDT (= drugs + bioreactor) causes >1 year of leg growth. 2) very large, *adult* Xenopus (not just froglets/juveniles) 1/n
0
0
2
@EvanFox22
Evan Fox
4 years
Wonderful progress Lew and team @IntensityInc
@IntensityInc
Intensity Therapeutics
4 years
Two days, 2 news announcements about our 3 presentations at both the annual #CTOS2021 and #sitc2021 (2) meetings. Promising survival data reported in sarcoma, a cancer with unmet medical need.
0
0
1
@EvanFox22
Evan Fox
4 years
Amazing project incoming from the incredibly talented @JulianMMarshall
0
0
2
@EvanFox22
Evan Fox
5 years
Congrats to the team @RelationRx πŸ™ŒπŸ»
@RelationRx
Relation
5 years
Hi everyone, we're pleased to announce our manuscript was published in Briefings in Bioinformatics, see https://t.co/WORqK7MXRn! Debating doing a summary thread of key advances in GML in the coming days :P
0
0
1
@EvanFox22
Evan Fox
5 years
Congrats to @juvlabs on the launch of their first product, Metabolic Switch! 🀚
0
0
1
@EvanFox22
Evan Fox
5 years
Beautiful new website which fully captures the strengths and immense progress made of Intensity's INT230-6 platform
@IntensityInc
Intensity Therapeutics
5 years
We’re excited to announce that we have refreshed the Intensity Therapeutics website today! Go check it out:
0
0
1
@EvanFox22
Evan Fox
5 years
On a roll. Congrats again
@IntensityInc
Intensity Therapeutics
5 years
Two days, two patents in two countries! We've been granted our first Mexico patent, titled β€œA Therapeutic Agent And An Intracellular Permeation Enhancing Agent For Use In The Treatment Of Cancer” #SolidTumors
0
0
2
@EvanFox22
Evan Fox
5 years
Well done Lew & team!
@IntensityInc
Intensity Therapeutics
5 years
Today Intensity Therapeutics was granted our 3rd US Patent, further validating our novel #intratumoral injection approach to treating #cancer. Learn more: https://t.co/x7UH8kIulJ #USPatent #SolidTumors
0
0
1
@EvanFox22
Evan Fox
5 years
Favorite non-dog related tweet of the past few years
0
0
1
@EvanFox22
Evan Fox
5 years
🐢πŸ₯Ί
@dog_rates
WeRateDogs
5 years
The Dogs of 2020
0
0
1
@EvanFox22
Evan Fox
5 years
Amazing progress. Congrats to Lew and the whole @IntensityInc team. Can’t wait to see what the next year brings πŸ™ŒπŸ»
@IntensityInc
Intensity Therapeutics
5 years
Intensity Therapeutics Reports Favorable Data of INT230-6 from the Ongoing Phase 1/2 Study (IT-01/KEYNOTE A10) in Patients with Advanced Solid Tumors at SITC 2020 (Abstract 411)
0
0
1
@EvanFox22
Evan Fox
5 years
Reimagine a lifetime 🀚🏻
0
0
2
@EvanFox22
Evan Fox
5 years
πŸ”₯πŸ”₯πŸ”₯πŸ’°πŸ’°πŸ’°
@JoeBiden
Joe Biden
5 years
Pitch in $5 to help this campaign fly. https://t.co/CqHAId0j8t
0
0
2
@SenAmyKlobuchar
Senator Amy Klobuchar
5 years
Watch my entire response to Senator Ted Cruz about the Supreme Court vacancy:
5K
28K
89K